This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Compare brokers on index fund selections, focusing on fund variety, fees, and ease of use to pick the best platform for your needs.
28,035 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Tech-heavy Nasdaq faces renewed pressure as crude prices push above $100 a barrel. Traders weigh how energy inflation...
Global markets tumble as President Trump’s policy shifts on Iran fuel uncertainty. Investors scramble to gauge exit p...
Builders entered the mid-year period wary, as tepid spring selling collided with strong headwinds for loans and mortg...
A Korea-led chip selloff pulled AMD and Intel lower while Nvidia slipped, prompting analysts to frame the move as hea...
Oil-led gains and geopolitical risk push the dollar to multi-year highs, with traders haven’t been this bullish on th...
Tech stocks retreat as chipmakers drag the Nasdaq lower and rising yields weigh on growth names after a stronger jobs...
U.S. stocks opened the second half of 2026 with a cautious tone as chip stock profit-taking cooled a brisk first half...
A rare NYC moment offers more than fashion gossip — it highlights how wealthy couples manage money under scrutiny. Th...
Tech leaders are shifting in 2026, prompting a clash between QQQ and VGT for access to Big Tech. This report breaks d...
Two leveraged gold bets, DGP and UGL, jump with gold but carry different risk profiles. This analysis explains the st...
JEPI investors missed 13.21% gains in a strong market as an options overlay muted upside and taxes eroded income. Thi...